van Eck van der Sluijs, Jesper http://orcid.org/0000-0003-3136-7799
van Ens, Diede http://orcid.org/0000-0001-7273-4896
Brummelman, Jolanda http://orcid.org/0000-0003-3581-4816
Heister, Daan
Sareen, Aastha
Truijen, Lisa
van Ingen Schenau, Dorette S.
Heemskerk, Mirjam H. M. http://orcid.org/0000-0001-6320-9133
Griffioen, Marieke http://orcid.org/0000-0002-3001-4441
Kester, Michel G. D. http://orcid.org/0000-0002-8960-7348
Schaap, Nicolaas P. M. http://orcid.org/0000-0001-7696-4752
Jansen, Joop H. http://orcid.org/0000-0001-9459-568X
van der Waart, Anniek B. http://orcid.org/0000-0001-5986-3060
Dolstra, Harry http://orcid.org/0000-0002-3998-687X
Hobo, Willemijn http://orcid.org/0000-0002-8206-8185
Funding for this research was provided by:
KWF Kankerbestrijding (10351)
Article History
Received: 29 May 2023
Revised: 26 July 2023
Accepted: 11 August 2023
First Online: 20 September 2023
Declarations
:
: The authors declare that they have no competing interests.
: All patient material was obtained in accordance with the Declaration of Helsinki and institutional guidelines and regulations, and was approved by the Radboudumc CMO-light committee for medical research (Title project ‘Protocol restmateriaal en extra afnamen hematologie’, approval number CMO 2013/064, date of approval 30 October 2013). Informed consent was obtained from all individual participants included in this study. Animal experiments were approved by the Dutch Central Committee of Animal Experiments (CCD 2015–0120 and 2018–0029) and the Animal Experimental Committee of the Radboudumc. Experiments were performed in accordance with national and institutional guidelines and compliant with relevant legislation under the university permit number 10300.
: All patient material was obtained in accordance with the Declaration of Helsinki and institutional guidelines and regulations (CMO 2013/064). Individuals are not re-traceable, no patient characteristics are included, full anonymity is guaranteed.